During the past decade, Urological Associates of Southern Arizona conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 18 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 11 clinical trials were completed. i.e. 44% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urological Associates of Southern Arizona" #1 sponsor was "Pfizer" with 10 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Allena Pharmaceuticals" with 3 trials sponsored, "Dendreon" with 3 trials sponsored and "ASTORA Women's Health" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urological Associates of Southern Arizona" #1 collaborator was "Astellas Pharma Inc" with 5 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "Data & Inference, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "H2O Clinical LLC" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Urological Associates of Southern Arizona" are "Prostate Cancer" (8 trials), "Bladder Cancer" (5 trials), "Urinary Bladder Neoplasms" (4 trials), "Cancer of the Prostate" (3 trials) and "Overactive Bladder" (3 trials). Many other conditions were trialed in "Urological Associates of Southern Arizona" in a lesser frequency.

Most popular intervention types in "Urological Associates of Southern Arizona" are "Drug" (39 trials), "Device" (11 trials), "Biological" (10 trials), "Procedure" (6 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Enzalutamide" (3 trials), "Prednisone" (3 trials), "sipuleucel-T" (3 trials) and "Apalutamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Urological Associates of Southern Arizona" are 27 trials for "Male" genders, 24 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Urological Associates of Southern Arizona". undefined are not yet recruiting, 12 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Urological Associates of Southern Arizona, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Urological Associates of Southern Arizona, 7 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 9 trials that are defined as “Not Applicable".